[Dilip Davda] AHL is engaged in developing/manufacturing/marketing diverse range of sterile liquid pharma products. It posted almost static top lines for the reported periods. It suffered for FY23 and FY24 on account MAT incentive reversals and other related adjustments. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears exorbitantly priced. Only well-informed/cash surplus investors may park moderate funds for medium term/ others can stay away. Read detail review...

Amanta Healthcare IPO Peer Comparison

Amanta Healthcare Ltd. peer comparison with similar listed entities. (As on March 31, 2025)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Amanta Healthcare Limited	3.71	3.71	33.43	33.92	10.89	3.82
Denis Chem Lab Ltd	5.82	5.82	61.33	15.92	9.49	1.51	Standalone

Source: Financial information for listed industry peers mentioned above is based on annual reports of peer companies for the year ended March 31, 2025 submitted to stock exchanges and concerning the company, the information is based on Restated Financial Information for the year ended March 31, 2025.

Notes:

All the financial information for listed industry peers mentioned above is standalone.
Basic & Diluted earnings/(loss) per share for peers sourced from the annual report for the Financial Year 2025, whereas for the Company, it is based on the Restated Financial Information of the Company.
The P/E Ratio has been computed based on the closing market price of equity shares on BSE on March 31, 2025, divided by the Diluted EPS.
RoNW means Restated Profit/(Loss) for the year divided by Net worth as at the end of the relevant fiscal.
Net Asset Value (NAV) per Equity Share = Net worth divided by the outstanding number of equity shares at the end of the financial year.

Amanta Healthcare IPO Review by Members

Amanta Healthcare IPO Reviews, analysis and views by popular members. Read Amanta Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Amanta Healthcare IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Amanta Healthcare IPO Review & Recommendations

Amanta Healthcare IPO Review Summary from brokers and analysts

Amanta Healthcare IPO Capital Market Rating

Amanta Healthcare IPO Review by Dilip Davda Not Rated

Amanta Healthcare IPO Peer Comparison

Amanta Healthcare IPO Review by Members

Amanta Healthcare IPO Review Summary by Members

Read more about Amanta Healthcare IPO